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Tumor necrosis factor a (TNFa), a secretory product of activated macrophages
(1), has been shown to have multiple inflammatory and immunoregulatory proper-
ties, including the induction of release of IL-1 by monocytes and endothelial cells
(2-3), alteration of antigenic expression on (4) and direct toxicity to (5) vascular
endothelium, activation of NK cells (6), and stimulation of T cell proliferation and
production of IFN-y (7). In the MRL/Ipr mouse strain, a murine model of autoim-
munity and vasculitis (reviewed in reference 8), endogenous activation of macro-
phages (9-10) and hepatic NK cells (11) has been described. We report here that
freshly isolated, unstimulated Kupffer cells (KC) from MRL/Ipr female mice spon-
taneously produce high levels of TNFa in short-term culture.
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Mice.
￿
C3H/HeN, C3H/Hej, BALB/c DBA/2J, (NZB x NZW)F,, C57BL/6, MRL/
MpJ-lpr/lpr (MRL-Ipr), and MRL/MpJ-+/+ (MRL-+/+) female mice 3-40 wk old were
obtained from colonies from The Jackson Laboratories, Bar Harbor, ME. The mice were
housed in barrier facilities with sterile caging, bedding, water, and food. They were screened
routinely for pathogens.
Reagents and Cells.
￿
Collagenase IV, Metrizamide, and LPS were purchased from Sigma
Chemical Co., St. Louis, MO. Mouse IFN-y was purchased from Lee Biomolecular Research
Laboratories, Inc., San Diego, CA. MTT (3-(4,5-dimethylthiazol-2 yl)-2,5-diphenyl tetrazo-
lium bromide) was purchased from Molecular Devices, Palo Alto, CA. Corynebacterium parvum
was purchased from Burroughs Wellcome Co., Research Triangle Park, NC. Rabbit antisera
to recombinant mouse TNFa was kindly provided by Genentech, Inc., South San Francisco,
CA.
Kupffer Cell Isolation.
￿
Under sterile conditions, hepatic nonparenchymal cells (NPC) were
purified as described previously (11) by collagenase perfusion of the portal vein and Metriza-
mide density centrifugation. Total recovery ranged from 0.2 to 1.2 x 10' NPC per liver. Con-
tamination by hepatocytes, as determined by counting 200 cells from the preparation, was
<I%. After washing twice, the NPC were resuspended at a concentration of 106 cells/ml in
complete media containing RPMI 1640 plus 517o FCS, penicillin, and streptomycin, and were
adhered to flat-bottomed 24-well microtiter plates (Costar, Cambridge, MA) for 90 min at
37°C (5% C02, 100% humidity). The supernatant was removed by vigorous pipetting.
35-40% of NPC were adherent and >90% of the adherent cells were nonspecific esterase-
positive in all mouse strains. 1 ml of fresh complete media was then added to each well. KC
were cultured for 24 h in complete media. The supernatants were then harvested, centrifuged
at 400 g to remove cells, and stored at 4°C before being assayed for TNF.
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In selected wells, 0.01-1.0 gg of LPS (in 10 gl) was added after adherence. After 2 h the
supernatants were removed by pipetting; the adherent cells were washed twice and cultured
for 24 h in complete media. The supernatants were then harvested as above.
Assayfor Endotoxin.
￿
Media and perfusates were assayed for the presence of endotoxin by
the Limulus amebocyte lysate agglutination (No. 210-A; Sigma Chemical Co.) (12).
Assayfor Tumor Necrosis Factor.
￿
The UVinduced 1591-RE tumor cell line has been shown
to be highly sensitive to the cytotoxic activity of TNFa and TNF(3 and resistant to IL-1 in
vitro (13). A clone of this cell line, 1591-RE3.5, was used in these experiments. A standard
MTT assay described by Mosmann (14) was used to quantify TNF in cultured supernates.
Briefly, supernatants from KC in 100 Itl RPMI 1640 plus 5% FCS, penicillin, and strep-
tomycin were serially diluted in duplicate in 96-well microtiter trays (Dynatech Laboratories,
Inc., Alexandria, VA) and mixed with 5 x 103 1591 RE3 .5 tumor cells in 100 ltl of medium.
After a 72-h incubation at 37°C in a 5% C02 humidified incubator, 100 gI of the culture
media was removed and 20 ul ofMTT (5 mg/ml in PBS) were added per well and incubated
an additional 4 h. The formazan crystals were dissolved by overnight incubation with 100
pl of a 10% SDS-0.01 N HCl solution per well. Lysis was quantified on a microelisa reader
(model MR1000; Dynatech Laboratories, Inc.) using a 690-nm reference and a 570-nm test
filter. Optical density values were converted to percent cytotoxicity by comparing LD5o values
from untreated controls using the following formula: Percent cytotoxicity = 100 x [1-(OD
test/OD control)]. The LD5o of 1591-RE3.5 cell line is 0.158 ± 0.01 U/ml using a recom-
binant human TNFa (sp act 5 x 107 U/mg; Genentech, Inc.) as a reference source of TNF.
Picomolar values were based upon the average molecular weight of TNF-a (17,000 mol wt).
Results and Discussion
Using a cytotoxicity assay against a TNFa- and TNFR-sensitive, IL-1 resistant
cell line, we have found that freshly isolated, unstimulated KC from MRL/lpr fe-
male mice produce high levels of TNF in 24-h culture. TNF production was de-
tected in KC cultures from MRL/Ipr mice > 6 wk old and increased with age of
the mice (Fig. 1). Moreover, TNF production was also observed in splenic macro-
phages from MRL/Ipr mice >12 wk (data not shown). Pretreatment of the KC cul-
ture supernatants with an antiserum made against recombinant TNF eliminated
cytotoxicity to the 1591 RE 3 .5 cell line, suggesting that the adherent hepatic non-
parenchymal cells are producing TNFa and not lymphotoxin (Table I). Although
C.parvum in vivo (1.4 mg i.v. injection) could induce TNF production in KC in the
nonautoimmune C3H/HeN, BALB/c, DBA/2, and C57B16 strains, the only other
strain in which spontaneous TNF production by KC was consistently observed was
MRL/+ + mice >10 mo old.
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FIGURE 1.
￿
Tumor necrosis factor pro-
duction by Kupffer cells. 106 hepatic
NPC from female MRL/Ipr (0),
MRL/++ (p), and NZB x NZW)FI
(A) mice ofdifferent ages were adhered
to flat-bottomed 24-well microtiter
plates. The nonadherent cells were re-
moved by vigorous pipetting, and 1 ml
of RPMI 1640 + 5% FCS was added
to thewell. Aftera 24-h incubation, the
supernatant was assayed for TNF ac-
tivity by cytotoxicity to 1591 RE 3.5,
a TNT-sensitive, IL-1-resistant cellline.
The LD50 is 0.158 ± 0.01 U/ml. Pico-
molar values are based upon the sp act
of5 x 101 U/mg and molecular weight
of 17,000.90
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TABLE I
Cytotoxic Activity to 1591 RE 3.5 Tumor Cells of Cultured Supernatants
from MRL/1pr or Old MRL- + /+ Kupffer Cells Is Neutralized
by an Antibody to TNF-a
1/2 I/4 I/8 I/I6 I/32 1/64
Rabbit antiserum to recombinant murine TNF-a (4 x 105 neutralizing units/ml)
was preincubated with culture supernatants for 16 h at 37°C before the addition
of 1591RE-3 .5 targets. After an additional 72 h the assay was harvested as de-
scribed in Materials and Methods. Cultured supernatants were tested at a final
dilution of 1 :2 in the culture well (100 pl target cells, 100 wl culture superna-
tant). Without the addition ofantibody, the specific cytotoxicity of KC superna-
tants from 6-wk-old MRL/lpr was 97%, 10-wk-old MRL/lpr was 97%, and
40-wk-old MRL-+/+ was 95% .
TNF can be induced by sublethal injection ofendotoxin. However, it is unlikely
that contamination ofendotoxin is the cause ofthe spontaneous production ofTNRa
byKC in the MRL/lpr strain. Buffers, media, and perfusates were routinely tested
for the presence of LPS by the Limulus amebocyte lysate assay (12). Less than 0.1
ng/ml was detected. Moreover, macrophages from at least one other mouse strain
were usually isolated on the same day as MRL/lpr mice under identical conditions
with the sameperfusate preparations (Fig. 2). Thepossibility ofenhanced LPS sen-
sitivity of MRL/lpr KC to produce TNF has also been excluded. Indeed, we have
observed unresponsiveness to LPS in KC from older MRL/lpr mice. KC were in-
cubated for 2 h with increasing concentrations ofLPS (0.05-0.5 ug/ml). In contrast
to KC from nonautoimmunestrains, TNF production decreasedafter incubation with
LPS in KC from MRL/lpr mice >10 wk old (Fig. 3). In support ofthislatter finding
FIGURE 2.
￿
Tumor necrosis fac-
tor by Kupffer cells: cytotoxicity
to 1591 RE 3.5 tumor cells.
Single experiment in which 5 x
103 tumor cells were incubated
for 72 h with increasing dilu-
tions of Kupffer cell superna-
tants from 16-wk-old ("), 12-
wk-old (O), and 10-wk-old (/)
MRL/lpr, 16-wk-old C3H/HeN
(A); and 30-wk-old (NZB x
NZW)FI (Fl) female mice.
Percent inhibition of cytotoxicity
by anti-TNF-a antibody at
Kupffer cell culture a concentration (ml/well) of:
from mouse strain Age 2.5 5
wk
MRL/lpr 6 81 90
MRL/lpr 10 90 97
MRL-+/+ 40 84 89792
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FIGURE 3.
￿
In vitro effects of LPSon the TNF production by Kupffer
cells. Kupffer cells from different mouse strains were incubated with
0.05-05 gg/ml of LPS. After 2 h the wells were washed, and 1 ml of
RPMI 1640 + 5% FCS was added to the wells. After a 24-h incuba-
tion, the supernatants were assayed for TNF activity. (O) 12-wk-old
MRL/lpr; ( ") 12-wk-old MRL/++ ; (/) 10-wk-old C3H/HeN; (p)
13-wk-old C3H/Hej female mice.
is the recent report ofdefectiveinduction ofTNF by LPSin peritoneal exudate cells
from another autoimmune mouse strain, (NZB x NZW)F, (15).
Spontaneous TNF production by Kupffer cells ofMRL/lpr mice may only repre-
sent an epiphenomenon related to endogenous macrophage activation (9, 10, 16).
However, in addition to its metabolic, antitumor and antiviral properties (reviewed
in reference 17), TNF has pleiotropic immunoregulatory effects, including activa-
tion ofNK cells (6) and stimulation ofactivated T cells to proliferate and produce
IFN-y (7). Recently, Ghiara et al. (18) have demonstrated that TNRa can enhance
the immune response in vivo at doses farlower than required forantitumor activity.
Moreover, TNF has been shown to have profound in vitro effects on the vascular
endothelium which could initiate a local inflammatory response. Enhancement of
the expression ofHLA antigens (19), inhibition ofthe expression ofthrombomodulin
(20), and stimulation of the production of IL-1 (3) and procoagulant activity (21)
have been reported. TNF also stimulates neutrophilsboth to adhere to endothelium
(22) and, whenadherent, to releasehydrogen peroxide(23). Therefore, endogenous
production ofTNF in the liver may have a role in the pathogenesis ofboth the mul-
tiple immunoregulatory abnormalities (8)and the necrotizing vasculitis ofmedium-
sized arteries (25) in the MRL/lpr mouse.
Summary
We report that freshly isolated, unstimulated Kupffer cells (KC) from MRL/lpr
female mice in short-term culture spontaneously produce high levels ofTNRa. TNF
production was first detected in KC cultures at age 6 wk and increased with the
age ofthemice. Moreover, the levels ofspontaneous TNF production byKC directly
correlated with the age of the MRL/lpr mice. Although TNF production by KC
could be induced with C. parvum in vivo or LPS in vitro in all nonautoimmune
C3H/HeN, BALB/c, DBA/2, C57B16 mice, the only other strain in which sponta-
neous TNF production by KC was observed was MRL/++ mice >10 mo old.MAGILAVY AND ROTHSTEIN
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